Kyowa Kirin announced a new, state-of-the-art manufacturing facility in Sanford, North Carolina, US. Kyowa Kirin will invest up to $530 million (€489 million) in...
26.07.2017
- Shire has obtained exclusive worldwide rights from Novimmune for a bi-specific antibody that is currently in pre-clinical development for treating patients with the blood disorders...
12.06.2017
- UK biotech Glythera has launched a project to develop next-generation antibody drug conjugates (ADCs) for difficult-to-treat tumors, backed by funding of £1 million from government...
17.05.2017
- AstraZeneca is to collaborate with US-based Pieris Pharmaceuticals to develop novel inhaled drugs for respiratory diseases. The deal will leverage Pieris’ Anticalin platform and...
16.02.2017
- The UK’s Tusk Therapeutics is joining Cancer Research Technology (CRT) and University College London (UCL) to research, develop and commercialize an antibody-based therapeutic...
20.11.2013
- Dutch food and chemicals group DSM will spin off its pharmaceuticals unit into a new joint venture majority-owned by private equity firm JLL Partners as the company shifts its...
18.07.2012
- DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced that it has signed a biologics contract manufacturing agreement with its first...
05.05.2010
- DSM Biologics, a business unit of DSM Pharmaceutical products, said it has reached an agreement for the acquisition of the assets and associated business of the Rhobust technology...
